Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Mutation spectrum in children with primary hemophagocytic lymphohistiocytosis: molecular and functional analyses of PRF1, UNC13D, STX11, and RAB27A
- Udo Zur Stadt, K. Beutel, +4 authors Hans Christian Hennies
- Biology, Medicine
- Human mutation
- 1 January 2006
Familial hemophagocytic lymphohistiocytosis (FHL) is an autosomal‐recessive disease that affects young children. It presents as a severe hyperinflammatory syndrome with activated macrophages and T… Expand
A prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes.
- Y. Bryceson, D. Pende, +17 authors S. Ehl
- Biology, Medicine
- Blood
- 22 March 2012
Familial hemophagocytic lymphohistiocytosis (FHL) is a life-threatening disorder of immune regulation caused by defects in lymphocyte cytotoxicity. Rapid differentiation of primary, genetic forms… Expand
Distinct mutations in STXBP2 are associated with variable clinical presentations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL5).
Familial hemophagocytic lymphohistiocytosis (FHL) is a genetically determined hyperinflammatory syndrome caused by uncontrolled immune response mediated by T-lymphocytes, natural killer (NK) cells,… Expand
Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia–implications for treatment of infants
- R. Pieters, M. D. Boer, +5 authors A. Veerman
- Medicine
- Leukemia
- 1 September 1998
The prognosis of infant ALL, characterized by a high incidence of the immature CD10 negative B-lineage ALL (proB ALL) is poor. This study aimed to determine the resistance profile of infant ALL… Expand
Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11.
- U. zur Stadt, J. Rohr, +13 authors H. Hennies
- Biology, Medicine
- American journal of human genetics
- 9 October 2009
Rapid intracellular transport and secretion of cytotoxic granules through the immunological synapse requires a balanced interaction of several proteins. Disturbance of this highly regulated process… Expand
Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11.
- U. zur Stadt, Susanne Schmidt, +8 authors H. Hennies
- Biology, Medicine
- Human molecular genetics
- 15 March 2005
Familial hemophagocytic lymphohistiocytosis (FHL) is a rare autosomal recessive disorder characterized by hyperactive phagocytes and defects in natural killer cell function. It has been shown… Expand
Linkage of familial hemophagocytic lymphohistiocytosis to 10q21-22 and evidence for heterogeneity.
- R. Dufourcq-Lagelouse, N. Jabado, +8 authors G. de Saint Basile
- Biology, Medicine
- American journal of human genetics
- 1999
Familial hemophagocytic lymphohistiocytosis (FHL) is an autosomal recessive disorder characterized by the early onset of overwhelming activation of T lymphocytes and macrophages, invariably leading… Expand
Atypical familial hemophagocytic lymphohistiocytosis due to mutations in UNC13D and STXBP2 overlaps with primary immunodeficiency diseases
- Jan C. Rohr, K. Beutel, +17 authors S. Ehl
- Medicine
- Haematologica
- 1 December 2010
Background Familial hemophagocytic lymphohistiocytosis is a genetic disorder of lymphocyte cytotoxicity that usually presents in the first two years of life and has a poor prognosis unless treated by… Expand
Differentiating macrophage activation syndrome in systemic juvenile idiopathic arthritis from other forms of hemophagocytic lymphohistiocytosis.
- K. Lehmberg, I. Pink, C. Eulenburg, K. Beutel, A. Maul-Pavicic, G. Janka
- Medicine, Biology
- The Journal of pediatrics
- 1 June 2013
OBJECTIVES
To identify measures distinguishing macrophage activation syndrome (MAS) in systemic juvenile idiopathic arthritis (sJIA) from familial hemophagocytic lymphohistiocytosis (FHL) and… Expand
Outcome of congenital acute lymphoblastic leukemia treated on the Interfant-99 protocol.
- Marieke van der Linden, M. Valsecchi, +15 authors R. Pieters
- Medicine
- Blood
- 29 October 2009
Acute lymphoblastic leukemia (ALL) diagnosed in the first month of life (congenital ALL) is very rare. Although congenital ALL is often assumed to be fatal, no studies have been published on outcome… Expand